46 unchanged sentences
On April 24, 2024, the Board granted institution of IPR2024-00028 on the validity of all claims of the ’794 patent.
−Removed: The CUHK filed a response to the petition and institution decision on July 26, 2024.
−Removed: PacBio’s reply to CUHK’s response is due October 28, 2024.
On May 2, 2024, the parties filed a joint stipulation and proposed order to stay the Take2 District Court matter pending inter partes review.
−Removed: On May 3, 2024, the Court granted the motion to stay, and the case currently remains stayed.
−Removed: We intend to vigorously defend in this matter.
+Added: On May 3, 2024, the Court granted the motion to stay.
+Added: Briefing is complete in IPR2024-00028 and an oral hearing took place on January 23, 2025.
+Added: On March 7, 2025, we entered into a purchase agreement with CUHK to purchase the ‘794 patent.
+Added: In connection with our purchase of the ‘794 Patent, each of Take2 and CUHK, on the one hand, and PacBio, on the other hand, agreed to waive and seek the
+Added: Q1 Fiscal 2025 Form 10-Q
+Added: discharge of all outstanding litigation claims and patent-related challenges, including with respect to the Take2 District Court matter and IPR2024-00028.
+Added: The agreement to discharge the litigation claims and the patent challenge has been granted by the Northern District of California and the Board, respectively.
Proceedings in China
4 unchanged sentences
On September 2, 2021, the CNIPA issued its decision on the Invalidation Petition and determined that all claims (1-61) of the CN321 patent were invalid.
−Removed: On December 1, 2021, PGI filed an appeal with the Beijing IP Court, contesting the CNIPA decision, and the hearing was held on August 9, 2023.
−Removed: The Beijing IP Court issued a ruling maintaining the CNIPA’s invalidation decision on November 19, 2023.
−Removed: PGI appealed to the Supreme People’s Court on December 25, 2023.
+Added: On December 1, 2021, PGI filed an appeal with the Beijing IP Court, contesting the CNIPA decision.
We filed a petition with the Wuhan Intermediate People’s court requesting dismissal of the infringement action based on the CNIPA invalidation decision, and PGI filed a petition to withdraw its complaint.
7 unchanged sentences
Regardless of the outcome, litigation can have an adverse impact on us because of litigation and settlement costs, diversion of management resources, and other factors.
+Added: Q1 Fiscal 2025 Form 10-Q
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.